Get the Stockscreener App
0.4883
1.15%
-0.0057
Pre-market:
.48
-0.0083
-1.70%
BiomX Inc stock is traded at $0.4883, with a volume of 300.32K.
It is down -1.15% in the last 24 hours and down -5.73% over the past month.
BiomX Inc., a clinical stage company, develops bacteriophage-based therapies for the treatment and prevention of diseases from the microbiome. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), liver, primary sclerosing cholangitis, and cancer. The company's lead product candidate BX001, which is in phase I that helps to modify the appearance of skin in various skin types, including oily and acne-prone skin type; BX002, a therapeutic phage product to treat IBD; BX003, targets bacteria associated with progressive liver disorder (PSC), a rare inflammatory liver disease; and CRC, targets strains of bacteria found in colorectal cancer tumors. The company has license agreement collaboration with The Weizmann Institute of Science to develop, test, manufacture, produce, and sell microbiome-based therapeutic product candidate; Takeda, develops formulations for phage therapy manufacturing intermediates and for the final form to be administered; Keio University and JSR Corporation, a set of bacterial targets for the development and commercialization of phage therapies to treat IBD; and Janssen Research & Development, LLC to utilize XMarker microbiome-based biomarker discovery platform. BiomX Inc. was founded in 2015 and is headquartered in Ness Ziona, Israel.
See More
Previous Close:
$0.494
Open:
$0.494
24h Volume:
300.32K
Relative Volume:
0.08
Market Cap:
$12.97M
Revenue:
-
Net Income/Loss:
$-23.14M
P/E Ratio:
-0.482
EPS:
-1.0131
Net Cash Flow:
$-29.23M
1W Performance:
-16.53%
1M Performance:
-5.73%
6M Performance:
-16.53%
1Y Performance:
-32.96%
1-Day Range:
$0.4703
$0.5052
1-Week Range:
$0.4703
$0.606
52-Week Range:
$0.34
$1.1609
BiomX Inc Stock (PHGE) Company Profile
Name
BiomX Inc
Sector
Industry
Phone
972 7 23942377
Address
7 Pinhas Sapir Street, 2nd Floor, Ness Ziona
Compare PHGE with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHGE
BiomX Inc
|
0.4883 | 13.12M | 0 | -23.14M | -29.23M | -1.0131 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
BiomX Inc Stock (PHGE) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-15-21 | Initiated | Ladenburg Thalmann | Buy |
BiomX Inc Stock (PHGE) Latest News
Why BiomX Inc. stock could be top winner2025 Winners & Losers & Long-Term Growth Plans - newser.com
Will BiomX Inc. stock rise with strong economyWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Signal strength of BiomX Inc. stock in tech scanners2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Analyzing BiomX Inc. with multi timeframe chartsEarnings Overview Report & Capital Efficiency Focused Strategies - newser.com
How BiomX Inc. stock compares with tech leadersJuly 2025 Earnings & Long-Term Safe Return Strategies - newser.com
Why BiomX Inc. stock remains resilientEarnings Recap Report & Entry Point Confirmation Alerts - newser.com
Predicting BiomX Inc. trend using moving averages2025 Trade Ideas & Fast Exit and Entry Trade Guides - newser.com
Will BiomX Inc. stock draw ESG focused fundsGlobal Markets & Smart Money Movement Tracker - newser.com
What recovery options are there for BiomX Inc.2025 Market Overview & Technical Pattern Based Signals - newser.com
Forecasting BiomX Inc. price range with options dataJuly 2025 Opening Moves & Consistent Income Trade Ideas - newser.com
How BiomX Inc. stock reacts to inflationary pressures2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
Using RSI to spot recovery in BiomX Inc.2025 Valuation Update & Stepwise Entry and Exit Trade Signals - newser.com
Why BiomX Inc. stock remains stableEarnings Miss & Weekly Watchlist of Top Performers - newser.com
Full technical analysis of BiomX Inc. stock2025 Key Lessons & Smart Money Movement Tracker - newser.com
Will BiomX Inc. stock gain from green policies2025 Key Lessons & Weekly Breakout Stock Alerts - newser.com
Is BiomX Inc. stock cheap at current valuation2025 Market Trends & Long-Term Growth Stock Strategies - newser.com
BiomX Inc Stock (PHGE) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):